Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-26-027330
Filing Date
2026-04-27
Accepted
2026-04-27 08:00:48
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A novavaxincdefa14a2026.htm DEFA14A 9584
2 defa14a_1a.jpg GRAPHIC 494590
3 defa14a_2a.jpg GRAPHIC 500047
  Complete submission text file 0001628280-26-027330.txt   1379931
Mailing Address 21 FIRSTFIELD RD GAITHERSBURG MD
Business Address 21 FIRSTFIELD RD GAITHERSBURG MD 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26770 | Film No.: 26896611
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)